{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T16:39:40Z","timestamp":1770050380215,"version":"3.49.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T00:00:00Z","timestamp":1725235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T00:00:00Z","timestamp":1725235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Research studies typically quantify acute respiratory exacerbation episodes (AECOPD) among people with chronic obstructive pulmonary disease (COPD) based on self-report elicited by survey questionnaire. However, AECOPD quantification by self-report could be inaccurate, potentially rendering it an imprecise tool for identification of those with exacerbation tendency.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Determine the agreement between self-reported and health records-documented quantification of AECOPD and their association with airway inflammation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We administered a questionnaire to elicit the incidence and severity of respiratory exacerbations in the three years preceding the survey among current or former heavy smokers with or without diagnosis of COPD. We then examined electronic health records (EHR) of those with COPD and those without (tobacco-exposed persons with preserved spirometry or TEPS) to determine whether the documentation of the three-year incidence of moderate to very severe respiratory exacerbations was consistent with self-report using Kappa Interrater statistic. A subgroup of participants also underwent bronchoalveolar lavage (BAL) to quantify their airway inflammatory cells. We further used multivariable regressions analysis to estimate the association between respiratory exacerbations and BAL inflammatory cell composition with adjustment for covariates including age, sex, height, weight, smoking status (current versus former) and burden (pack-years).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Overall, a total of 511 participants completed the questionnaire, from whom 487 had EHR available for review. Among the 222 participants with COPD (70\u2009\u00b1\u20097\u00a0years-old; 96% male; 70\u2009\u00b1\u200938 pack-years smoking; 42% current smoking), 57 (26%) reported having any moderate to very severe AECOPD (m\/s-AECOPD) while 66 (30%) had EHR documentation of m\/s-AECOPD. However, 42% of those with EHR-identified m\/s-AECOPD had none by self-report, and 33% of those who reported m\/s-AECOPD had none by EHR, suggesting only moderate agreement (Cohen\u2019s Kappa\u2009=\u20090.47\u2009\u00b1\u20090.07;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001). Nevertheless, self-reported and EHR-identified m\/s-AECOPD events were both associated with higher BAL neutrophils (\u00df\u2009\u00b1\u2009SEM: 3.0\u2009\u00b1\u20091.1 and 1.3\u2009\u00b1\u20090.5 per 10% neutrophil increase;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009\u2264\u20090.018) and lymphocytes (0.9\u2009\u00b1\u20090.4 and 0.7\u2009\u00b1\u20090.3 per 10% lymphocyte increase;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009\u2264\u20090.041). Exacerbation by either measure combined was associated with a larger estimated effect (3.7\u2009\u00b1\u20091.2 and 1.0\u2009\u00b1\u20090.5 per 10% increase in neutrophils and lymphocytes, respectively) but was not statistically significantly different compared to the self-report only approach. Among the 184 TEPS participants, there were fewer moderate to very severe respiratory exacerbations by self-report (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200915 or 8%) or EHR-documentation (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20099 or 5%), but a similar level of agreement as those with COPD was observed (Cohen\u2019s Kappa\u2009=\u20090.38\u2009\u00b1\u20090.07;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>While there is modest agreement between self-reported and EHR-identified m\/s-AECOPD, events are missed by relying on either method alone. However, m\/s-AECOPD quantified by self-report or health records is associated with BAL neutrophilia and lymphocytosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12890-024-03239-8","type":"journal-article","created":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T07:02:16Z","timestamp":1725260536000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Self-report underestimates the frequency of the acute respiratory exacerbations of COPD but is associated with BAL neutrophilia and lymphocytosis: an observational study"],"prefix":"10.1186","volume":"24","author":[{"given":"Yorusaliem","family":"Abrham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siyang","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin","family":"Lo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Beckert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurel","family":"Evans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Giang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krish","family":"Thakkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian","family":"Roman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul D.","family":"Blanc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehrdad","family":"Arjomandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,2]]},"reference":[{"issue":"11","key":"3239_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0030442","volume":"3","author":"CD Mathers","year":"2006","unstructured":"Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11): e442.","journal-title":"PLoS Med"},{"issue":"5 Pt 1","key":"3239_CR2","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1164\/ajrccm.157.5.9709032","volume":"157","author":"TA Seemungal","year":"1998","unstructured":"Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157(5 Pt 1):1418\u201322.","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"3239_CR3","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1136\/thx.2005.040527","volume":"60","author":"JJ Soler-Catalu\u00f1a","year":"2005","unstructured":"Soler-Catalu\u00f1a JJ, Mart\u00ednez-Garc\u00eda MA, Rom\u00e1n S\u00e1nchez P, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60(11):925\u201331.","journal-title":"Thorax"},{"issue":"3","key":"3239_CR4","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1164\/rccm.201605-1014OC","volume":"195","author":"MT Dransfield","year":"2017","unstructured":"Dransfield MT, Kunisaki KM, Strand MJ, et al. Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2017;195(3):324\u201330.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"3239_CR5","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1001\/jama.2023.11676","volume":"330","author":"W McKleroy","year":"2023","unstructured":"McKleroy W, Shing T, Anderson WH, et al. Longitudinal Follow-Up of Participants With Tobacco Exposure and Preserved Spirometry. JAMA. 2023;330(5):442\u201353.","journal-title":"JAMA"},{"issue":"1","key":"3239_CR6","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3109\/15412550903499522","volume":"7","author":"EA Regan","year":"2010","unstructured":"Regan EA, Hokanson JE, Murphy JR, et al. Genetic epidemiology of COPD (COPDGene) study design. COPD. 2010;7(1):32\u201343.","journal-title":"COPD"},{"issue":"5","key":"3239_CR7","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1136\/thoraxjnl-2013-203897","volume":"69","author":"D Couper","year":"2014","unstructured":"Couper D, LaVange LM, Han M, et al. Design of the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS). Thorax. 2014;69(5):491\u20134.","journal-title":"Thorax"},{"key":"3239_CR8","doi-asserted-by":"crossref","unstructured":"Mathioudakis AG, Moberg M, Janner J, Alonso-Coello P, Vestbo J. Outcomes reported on the management of COPD exacerbations: a systematic survey of randomised controlled trials. ERJ Open Res. 2019;5(2):00072\u20132019.","DOI":"10.1183\/23120541.00072-2019"},{"issue":"3","key":"3239_CR9","doi-asserted-by":"publisher","first-page":"1600791","DOI":"10.1183\/13993003.00791-2016","volume":"49","author":"AW Jadwiga","year":"2017","unstructured":"Jadwiga AW, Marc M, John RH, et al. Management of COPD exacerbations: a European Respiratory Society\/American Thoracic Society guideline. Eur Respir J. 2017;49(3):1600791.","journal-title":"Eur Respir J"},{"issue":"3","key":"3239_CR10","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1183\/09031936.00035909","volume":"37","author":"JK Quint","year":"2011","unstructured":"Quint JK, Donaldson GC, Hurst JR, Goldring JJP, Seemungal TR, Wedzicha JA. Predictive accuracy of patient-reported exacerbation frequency in COPD. Eur Respir J. 2011;37(3):501\u20137.","journal-title":"Eur Respir J"},{"issue":"3","key":"3239_CR11","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3109\/15412555.2013.795423","volume":"10","author":"NK Leidy","year":"2013","unstructured":"Leidy NK, Murray LT. Patient-reported outcome (PRO) measures for clinical trials of COPD: the EXACT and E-RS. COPD. 2013;10(3):393\u20138.","journal-title":"COPD"},{"issue":"3","key":"3239_CR12","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1183\/09031936.00158613","volume":"43","author":"DA Shawn","year":"2014","unstructured":"Shawn DA. Measuring and quantifying acute exacerbations of COPD: pitfalls and practicalities. Eur Respir J. 2014;43(3):662\u20134.","journal-title":"Eur Respir J"},{"issue":"4","key":"3239_CR13","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1183\/09031936.00180812","volume":"41","author":"B Bianca","year":"2013","unstructured":"Bianca B, Alessia V, Mihai R, Leonardo MF. Exacerbation of respiratory symptoms in COPD patients may not be exacerbations of COPD. Eur Respir J. 2013;41(4):993\u20135.","journal-title":"Eur Respir J"},{"issue":"4","key":"3239_CR14","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.chest.2016.06.031","volume":"150","author":"A Frei","year":"2016","unstructured":"Frei A, Siebeling L, Wolters C, et al. The Inaccuracy of Patient Recall for COPD Exacerbation Rate Estimation and Its Implications: Results from Central Adjudication. Chest. 2016;150(4):860\u20138.","journal-title":"Chest"},{"issue":"8","key":"3239_CR15","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1136\/thoraxjnl-2013-205048","volume":"69","author":"WC Tan","year":"2014","unstructured":"Tan WC, Bourbeau J, Hernandez P, et al. Exacerbation-like respiratory symptoms in individuals without chronic obstructive pulmonary disease: results from a population-based study. Thorax. 2014;69(8):709\u201317.","journal-title":"Thorax"},{"issue":"6","key":"3239_CR16","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1165\/rcmb.2020-0085OC","volume":"63","author":"S Vasudevan","year":"2020","unstructured":"Vasudevan S, V\u00e1squez JJ, Chen W, et al. Lower PDL1, PDL2, and AXL Expression on Lung Myeloid Cells Suggests Inflammatory Bias in Smoking and Chronic Obstructive Pulmonary Disease. Am J Respir Cell Mol Biol. 2020;63(6):780\u201393.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"5147","key":"3239_CR17","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1136\/bmj.2.5147.257","volume":"2","author":"CM Fletcher","year":"1959","unstructured":"Fletcher CM, Elmes PC, Fairbairn AS, Wood CH. The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. Br Med J. 1959;2(5147):257\u201366.","journal-title":"Br Med J"},{"issue":"1","key":"3239_CR18","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1177\/135581969700200105","volume":"2","author":"C Jenkinson","year":"1997","unstructured":"Jenkinson C, Layte R. Development and testing of the UK SF-12 (short form health survey). J Health Serv Res Policy. 1997;2(1):14\u20138.","journal-title":"J Health Serv Res Policy"},{"issue":"3","key":"3239_CR19","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1183\/09031936.00102509","volume":"34","author":"PW Jones","year":"2009","unstructured":"Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline LN. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009;34(3):648\u201354.","journal-title":"Eur Respir J"},{"key":"3239_CR20","unstructured":"Comroe Jr. JH. Pulmonary function tests. Methods in Medical Research. Chicago: Year Book Publishers, Inc;\u00a01950."},{"issue":"4","key":"3239_CR21","first-page":"571","volume":"97","author":"MM Mitchell","year":"1968","unstructured":"Mitchell MM, Renzetti AD Jr. Evaluation of a single-breath method of measuring total lung capacity. Am Rev Respir Dis. 1968;97(4):571\u201380.","journal-title":"Am Rev Respir Dis"},{"issue":"4","key":"3239_CR22","first-page":"580","volume":"130","author":"CB Burns","year":"1984","unstructured":"Burns CB, Scheinhorn DJ. Evaluation of single-breath helium dilution total lung capacity in obstructive lung disease. Am Rev Respir Dis. 1984;130(4):580\u20133.","journal-title":"Am Rev Respir Dis"},{"issue":"3","key":"3239_CR23","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1172\/JCI103281","volume":"35","author":"AB Dubois","year":"1956","unstructured":"Dubois AB, Botelho SY, Bedell GN, Marshall R, Comroe JH Jr. A rapid plethysmographic method for measuring thoracic gas volume: a comparison with a nitrogen washout method for measuring functional residual capacity in normal subjects. J Clin Invest. 1956;35(3):322\u20136.","journal-title":"J Clin Invest"},{"issue":"3","key":"3239_CR24","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1172\/JCI103282","volume":"35","author":"AB Dubois","year":"1956","unstructured":"Dubois AB, Botelho SY, Comroe JH Jr. A new method for measuring airway resistance in man using a body plethysmograph: values in normal subjects and in patients with respiratory disease. J Clin Invest. 1956;35(3):327\u201335.","journal-title":"J Clin Invest"},{"issue":"9","key":"3239_CR25","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1172\/JCI103715","volume":"37","author":"WA Briscoe","year":"1958","unstructured":"Briscoe WA, Dubois AB. The relationship between airway resistance, airway conductance and lung volume in subjects of different age and body size. J Clin Invest. 1958;37(9):1279\u201385.","journal-title":"J Clin Invest"},{"issue":"1 Part 1","key":"3239_CR26","first-page":"1","volume":"36","author":"WS Blakemore","year":"1957","unstructured":"Blakemore WS, Forster RE, Morton JW, Ogilvie CM. A standardized breath holding technique for the clinical measurement of the diffusing capacity of the lung for carbon monoxide. J Clin Invest. 1957;36(1 Part 1):1\u201317.","journal-title":"J Clin Invest"},{"key":"3239_CR27","doi-asserted-by":"crossref","unstructured":"Standardization of Spirometry, 1994 Update. American thoracic society. Am J Respir Crit Care Med. 1995;152(3):1107\u201336.","DOI":"10.1164\/ajrccm.152.3.7663792"},{"issue":"4","key":"3239_CR28","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1183\/09031936.05.00034905","volume":"26","author":"N Macintyre","year":"2005","unstructured":"Macintyre N, Crapo RO, Viegi G, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J. 2005;26(4):720\u201335.","journal-title":"Eur Respir J"},{"issue":"1","key":"3239_CR29","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1183\/09031936.05.00034505","volume":"26","author":"MR Miller","year":"2005","unstructured":"Miller MR, Crapo R, Hankinson J, et al. General considerations for lung function testing. Eur Respir J. 2005;26(1):153\u201361.","journal-title":"Eur Respir J"},{"issue":"2","key":"3239_CR30","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1183\/09031936.05.00034805","volume":"26","author":"MR Miller","year":"2005","unstructured":"Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319\u201338.","journal-title":"Eur Respir J"},{"issue":"5","key":"3239_CR31","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1183\/09031936.05.00035205","volume":"26","author":"R Pellegrino","year":"2005","unstructured":"Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26(5):948\u201368.","journal-title":"Eur Respir J"},{"issue":"3","key":"3239_CR32","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1183\/09031936.05.00035005","volume":"26","author":"J Wanger","year":"2005","unstructured":"Wanger J, Clausen JL, Coates A, et al. Standardisation of the measurement of lung volumes. Eur Respir J. 2005;26(3):511\u201322.","journal-title":"Eur Respir J"},{"issue":"4","key":"3239_CR33","doi-asserted-by":"publisher","first-page":"2300239","DOI":"10.1183\/13993003.00239-2023","volume":"61","author":"A Alvar","year":"2023","unstructured":"Alvar A, Bartolome RC, Gerard JC, et al. Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary. Eur Respir J. 2023;61(4):2300239.","journal-title":"Eur Respir J"},{"issue":"4","key":"3239_CR34","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1164\/rccm.201607-1330OC","volume":"195","author":"JD Keene","year":"2017","unstructured":"Keene JD, Jacobson S, Kechris K, et al. Biomarkers Predictive of Exacerbations in the SPIROMICS and COPDGene Cohorts. Am J Respir Crit Care Med. 2017;195(4):473\u201381.","journal-title":"Am J Respir Crit Care Med"},{"issue":"14","key":"3239_CR35","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1056\/NEJMsa0803563","volume":"360","author":"SF Jencks","year":"2009","unstructured":"Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med. 2009;360(14):1418\u201328.","journal-title":"N Engl J Med"},{"issue":"16","key":"3239_CR36","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1056\/NEJMsa1513024","volume":"374","author":"RB Zuckerman","year":"2016","unstructured":"Zuckerman RB, Sheingold SH, Orav EJ, Ruhter J, Epstein AM. Readmissions, Observation, and the Hospital Readmissions Reduction Program. N Engl J Med. 2016;374(16):1543\u201351.","journal-title":"N Engl J Med"},{"issue":"4","key":"3239_CR37","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1164\/rccm.200502-272OC","volume":"172","author":"M Arjomandi","year":"2005","unstructured":"Arjomandi M, Witten A, Abbritti E, et al. Repeated exposure to ozone increases alveolar macrophage recruitment into asthmatic airways. Am J Respir Crit Care Med. 2005;172(4):427\u201332.","journal-title":"Am J Respir Crit Care Med"},{"key":"3239_CR38","doi-asserted-by":"publisher","unstructured":"Hall GL, Filipow N, Ruppel G, Okitika T, Thompson B, Kirkby J, Steenbruggen I, Cooper BG, Stanojevic S. Contributing GLI Network members. Official ERS technical standard: Global Lung Function Initiative reference values for static lung volumes in individuals of European ancestry. Eur Respir J. 2021;57(3):20002289.\u00a0https:\/\/doi.org\/10.1183\/13993003.00289-2020.","DOI":"10.1183\/13993003.00289-2020"},{"key":"3239_CR39","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1177\/001316446002000104","volume":"20","author":"J Cohen","year":"1960","unstructured":"Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Measur. 1960;20:37\u201346. https:\/\/doi.org\/10.1177\/001316446002000104.","journal-title":"Educ Psychol Measur"},{"issue":"1","key":"3239_CR40","doi-asserted-by":"publisher","first-page":"24122","DOI":"10.1038\/s41598-021-03476-5","volume":"11","author":"CC Derella","year":"2021","unstructured":"Derella CC, Tingen MS, Blanks A, et al. Smoking cessation reduces systemic inflammation and circulating endothelin-1. Sci Rep. 2021;11(1):24122.","journal-title":"Sci Rep"},{"issue":"3","key":"3239_CR41","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1136\/thx.2005.041822","volume":"61","author":"E Sapey","year":"2006","unstructured":"Sapey E, Stockley RA. COPD exacerbations. 2: aetiology. Thorax. 2006;61(3):250\u20138.","journal-title":"Thorax."},{"issue":"8","key":"3239_CR42","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1164\/rccm.200604-506OC","volume":"174","author":"JR Hurst","year":"2006","unstructured":"Hurst JR, Donaldson GC, Perera WR, et al. Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006;174(8):867\u201374.","journal-title":"Am J Respir Crit Care Med"},{"key":"3239_CR43","doi-asserted-by":"crossref","unstructured":"Langsetmo L, Platt RW, Ernst P, Bourbeau J. Underreporting exacerbation of chronic obstructive pulmonary disease in a longitudinal cohort. Am J Respir Crit Care Med. 2008;177(4):396\u2013401.","DOI":"10.1164\/rccm.200708-1290OC"},{"key":"3239_CR44","doi-asserted-by":"crossref","unstructured":"Vasudevan S, V\u00e1squez JJ, Chen W, et al. Lower PDL1\/2 and AXL Expression on lung myeloid cells suggests inflammatory bias in smoking and COPD. Am J Respir Cell Mol Biol. 2020;63(6):780\u201393.","DOI":"10.1165\/rcmb.2020-0085OC"},{"issue":"4","key":"3239_CR45","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1183\/09031936.05.00047504","volume":"25","author":"K Fujimoto","year":"2005","unstructured":"Fujimoto K, Yasuo M, Urushibata K, Hanaoka M, Koizumi T, Kubo K. Airway inflammation during stable and acutely exacerbated chronic obstructive pulmonary disease. Eur Respir J. 2005;25(4):640\u20136.","journal-title":"Eur Respir J"},{"issue":"2","key":"3239_CR46","doi-asserted-by":"publisher","first-page":"1900651","DOI":"10.1183\/13993003.00651-2019","volume":"54","author":"B Christopher","year":"2019","unstructured":"Christopher B, Neil G. Airway inflammation in COPD: progress to precision medicine. Eur Respir J. 2019;54(2):1900651.","journal-title":"Eur Respir J"},{"issue":"2","key":"3239_CR47","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1164\/ajrccm.153.2.8564092","volume":"153","author":"VM Keatings","year":"1996","unstructured":"Keatings VM, Collins PD, Scott DM, Barnes PJ. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med. 1996;153(2):530\u20134.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"3239_CR48","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1034\/j.1399-3003.1999.13d24.x","volume":"13","author":"RA Peleman","year":"1999","unstructured":"Peleman RA, Rytila PH, Kips JC, Joos GF, Pauwels RA. The cellular composition of induced sputum in chronic obstructive pulmonary disease. Eur Respir J. 1999;13(4):839\u201343.","journal-title":"Eur Respir J"},{"issue":"10","key":"3239_CR49","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1136\/thx.2003.019349","volume":"59","author":"RA O\u2019Donnell","year":"2004","unstructured":"O\u2019Donnell RA, Peebles C, Ward JA, et al. Relationship between peripheral airway dysfunction, airway obstruction, and neutrophilic inflammation in COPD. Thorax. 2004;59(10):837\u201342.","journal-title":"Thorax"},{"issue":"5","key":"3239_CR50","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1165\/rcmb.2012-0492TR","volume":"48","author":"K Hoenderdos","year":"2013","unstructured":"Hoenderdos K, Condliffe A. The Neutrophil in Chronic Obstructive Pulmonary Disease. Too Little, Too Late or Too Much, Too Soon? Am J Resp Cell Mol Biol. 2013;48(5):531\u20139.","journal-title":"Am J Resp Cell Mol Biol"},{"issue":"1","key":"3239_CR51","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1465-9921-11-77","volume":"11","author":"D Singh","year":"2010","unstructured":"Singh D, Edwards L, Tal-Singer R, Rennard S. Sputum neutrophils as a biomarker in COPD: findings from the ECLIPSE study. Respir Res. 2010;11(1):77.","journal-title":"Respir Res"},{"issue":"1","key":"3239_CR52","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1378\/chest.128.1.416","volume":"128","author":"M Arjomandi","year":"2005","unstructured":"Arjomandi M, Schmidlin I, Girling P, Boylen K, Ferrando R, Balmes J. Sputum induction and bronchoscopy for assessment of ozone-induced airway inflammation in asthma. Chest. 2005;128(1):416\u201323.","journal-title":"Chest"},{"issue":"3","key":"3239_CR53","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1164\/ajrccm.157.3.9709027","volume":"157","author":"M Saetta","year":"1998","unstructured":"Saetta M, Di Stefano A, Turato G, et al. CD8+ T-Lymphocytes in Peripheral Airways of Smokers with Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 1998;157(3):822\u20136.","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"3239_CR54","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1016\/j.rmed.2010.03.002","volume":"104","author":"J Olloquequi","year":"2010","unstructured":"Olloquequi J, Ferrer J, Montes JF, Rodr\u00edguez E, Montero MA, Garc\u00eda-Valero J. Differential lymphocyte infiltration in small airways and lung parenchyma in COPD patients. Respir Med. 2010;104(9):1310\u20138.","journal-title":"Respir Med"},{"issue":"1","key":"3239_CR55","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00011-020-01408-z","volume":"70","author":"M Williams","year":"2021","unstructured":"Williams M, Todd I, Fairclough LC. The role of CD8 + T lymphocytes in chronic obstructive pulmonary disease: a systematic review. Inflamm Res. 2021;70(1):11\u20138.","journal-title":"Inflamm Res"},{"issue":"6","key":"3239_CR56","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1164\/rccm.201104-0597OC","volume":"184","author":"M Bafadhel","year":"2011","unstructured":"Bafadhel M, McKenna S, Terry S, et al. Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. Am J Respir Crit Care Med. 2011;184(6):662\u201371.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"3239_CR57","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/1465-9921-12-127","volume":"12","author":"M Hardin","year":"2011","unstructured":"Hardin M, Silverman EK, Barr RG, et al. The clinical features of the overlap between COPD and asthma. Respir Res. 2011;12(1):127.","journal-title":"Respir Res"},{"issue":"6","key":"3239_CR58","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1183\/09031936.00162414","volume":"44","author":"D Singh","year":"2014","unstructured":"Singh D, Kolsum U, Brightling CE, Locantore N, Agusti A, Tal-Singer R. Eosinophilic inflammation in COPD: prevalence and clinical characteristics. Eur Respir J. 2014;44(6):1697\u2013700.","journal-title":"Eur Respir J"},{"issue":"12","key":"3239_CR59","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/S2213-2600(17)30432-0","volume":"5","author":"AT Hastie","year":"2017","unstructured":"Hastie AT, Martinez FJ, Curtis JL, et al. Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort. Lancet Respir Med. 2017;5(12):956\u201367.","journal-title":"Lancet Respir Med"},{"issue":"9240","key":"3239_CR60","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/S0140-6736(00)02872-5","volume":"356","author":"CE Brightling","year":"2000","unstructured":"Brightling CE, Monteiro W, Ward R, et al. Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial. Lancet. 2000;356(9240):1480\u20135.","journal-title":"Lancet"},{"issue":"1","key":"3239_CR61","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1164\/rccm.201108-1553OC","volume":"186","author":"M Bafadhel","year":"2012","unstructured":"Bafadhel M, McKenna S, Terry S, et al. Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial. Am J Respir Crit Care Med. 2012;186(1):48\u201355.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"3239_CR62","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.chest.2022.04.016","volume":"162","author":"L Trupin","year":"2022","unstructured":"Trupin L, Schmajuk G, Ying D, Yelin E, Blanc PD. Military Service and COPD Risk. Chest. 2022;162(4):792\u20135.","journal-title":"Chest"},{"key":"3239_CR63","unstructured":"Military service age and obligation. Central Intelligence Agency. The World Factbook 2024; https:\/\/www.cia.gov\/the-world-factbook\/field\/military-service-age-and-obligation\/. Accessed 04 June 2024."}],"updated-by":[{"DOI":"10.1186\/s12890-025-04076-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000}}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-024-03239-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-024-03239-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-024-03239-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T13:02:55Z","timestamp":1769691775000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12890-024-03239-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,2]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3239"],"URL":"https:\/\/doi.org\/10.1186\/s12890-024-03239-8","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,2]]},"assertion":[{"value":"21 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Following publication of the original article [1], an error was identified in the references. The updated references are given below and the changes have been highlighted in bold typeface.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12890-025-04076-z","URL":"https:\/\/doi.org\/10.1186\/s12890-025-04076-z","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in accordance with the Declaration of Helsinki. The University of California San Francisco (UCSF) Institutional Review Board (IRB) and the San Francisco Veterans Affairs Health Care System (SFVAHCS) Committee on Research and Development approved the study protocols. Written IRB-approved informed consent and Health Insurance Portability and Accountability Act (HIPAA) were obtained from all study participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"433"}}